129 related articles for article (PubMed ID: 8982686)
1. Interaction of S 21007 with 5-HT3 receptors. In vitro and in vivo characterization.
Delagrange P; Emerit MB; Merahi N; Abraham C; Morain P; Rault S; Renard P; Pfeiffer B; Guardiola-Lemaître B; Hamon M
Eur J Pharmacol; 1996 Dec; 316(2-3):195-203. PubMed ID: 8982686
[TBL] [Abstract][Full Text] [Related]
2. SR 57227A: a potent and selective agonist at central and peripheral 5-HT3 receptors in vitro and in vivo.
Bachy A; Héaulme M; Giudice A; Michaud JC; Lefevre IA; Souilhac J; Manara L; Emerit MB; Gozlan H; Hamon M
Eur J Pharmacol; 1993 Jun; 237(2-3):299-309. PubMed ID: 7689975
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of [14C]guanidinium accumulation in NG 108-15 cells exposed to serotonin 5-HT3 receptor ligands and substance P.
Emerit MB; Riad M; Fattaccini CM; Hamon M
J Neurochem; 1993 Jun; 60(6):2059-67. PubMed ID: 7684066
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological differences and similarities between the native mouse 5-HT3 receptor in N1E-115 cells and a cloned short splice variant of the mouse 5-HT3 receptor expressed in HEK 293 cells.
Brüss M; Molderings GJ; Bönisch H; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):225-33. PubMed ID: 10543422
[TBL] [Abstract][Full Text] [Related]
5. 5-HT3 receptor antagonism by anpirtoline, a mixed 5-HT1 receptor agonist/5-HT3 receptor antagonist.
Göthert M; Hamon M; Barann M; Bönisch H; Gozlan H; Laguzzi R; Metzenauer P; Nickel B; Szelenyi I
Br J Pharmacol; 1995 Jan; 114(2):269-74. PubMed ID: 7881726
[TBL] [Abstract][Full Text] [Related]
6. Facilitation by substance P and inhibition by (+)-tubocurarine of the 5-HT3 receptor-mediated Bezold-Jarisch reflex in rats.
Malinowska B; Godlewski G; Buczko W; Göthert M
Eur J Pharmacol; 1996 Nov; 315(2):159-64. PubMed ID: 8960879
[TBL] [Abstract][Full Text] [Related]
7. 5-HT3 receptor agonism may be responsible for the emetic effects of zacopride in the ferret.
Middlefell VC; Price TL
Br J Pharmacol; 1991 May; 103(1):1011-2. PubMed ID: 1831684
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid receptor-independent inhibition by cannabinoid agonists of the peripheral 5-HT3 receptor-mediated von Bezold-Jarisch reflex.
Godlewski G; Göthert M; Malinowska B
Br J Pharmacol; 2003 Mar; 138(5):767-74. PubMed ID: 12642377
[TBL] [Abstract][Full Text] [Related]
9. 1-(m-chlorophenyl)-biguanide, a potent high affinity 5-HT3 receptor agonist.
Kilpatrick GJ; Butler A; Burridge J; Oxford AW
Eur J Pharmacol; 1990 Jun; 182(1):193-7. PubMed ID: 2144822
[TBL] [Abstract][Full Text] [Related]
10. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
[TBL] [Abstract][Full Text] [Related]
11. (R) and (S) RS 56532: mixed 5-HT3 and 5-HT4 receptor ligands with opposing enantiomeric selectivity.
Eglen RM; Bonhaus DW; Clark RD; Johnson LG; Lee CH; Leung E; Smith WL; Wong EH; Whiting RL
Neuropharmacology; 1994; 33(3-4):515-26. PubMed ID: 7984291
[TBL] [Abstract][Full Text] [Related]
12. Characterization of 5-HT3 receptors of N1E-115 neuroblastoma cells by use of the influx of the organic cation [14C]-guanidinium.
Bönisch H; Barann M; Graupner J; Göthert M
Br J Pharmacol; 1993 Feb; 108(2):436-42. PubMed ID: 7680594
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed.
Leurs R; Tulp MT; Menge WM; Adolfs MJ; Zuiderveld OP; Timmerman H
Br J Pharmacol; 1995 Oct; 116(4):2315-21. PubMed ID: 8564266
[TBL] [Abstract][Full Text] [Related]
14. The enantiomers of zacopride: an intra-species comparison of their potencies in functional and anxiolytic models.
Bill DJ; Coleman J; Hallett I; Middlefell VC; Rhodes KF; Fletcher A
Br J Pharmacol; 1995 Jul; 115(5):775-80. PubMed ID: 8548176
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of 5-HT3 receptor function by imidazolines in mouse neuroblastoma cells: potential involvement of sigma 2 binding sites.
Molderings GJ; Schmidt K; Bönisch H; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):245-52. PubMed ID: 8878053
[TBL] [Abstract][Full Text] [Related]
16. The interaction of trichloroethanol with murine recombinant 5-HT3 receptors.
Downie DL; Hope AG; Belelli D; Lambert JJ; Peters JA; Bentley KR; Steward LJ; Chen CY; Barnes NM
Br J Pharmacol; 1995 Apr; 114(8):1641-51. PubMed ID: 7541281
[TBL] [Abstract][Full Text] [Related]
17. Activation of 5-HT3 receptors enhances the electrically evoked release of [3H]noradrenaline in rat brain limbic structures.
Mongeau R; De Montigny C; Blier P
Eur J Pharmacol; 1994 May; 256(3):269-79. PubMed ID: 8045271
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiological consequences of ligand binding to the desensitized 5-HT3 receptor in mammalian NG108-15 cells.
Bartrup JT; Newberry NR
J Physiol; 1996 Feb; 490 ( Pt 3)(Pt 3):679-90. PubMed ID: 8683467
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory effect of ethanol on the 5-hydroxytryptamine-induced Bezold-Jarisch reflex--involvement of peripheral 5-HT3 receptors.
Malinowska B; Göthert M; Godlewski G; Wróbel B; Bönisch H; Buczko W
Eur J Pharmacol; 1995 May; 293(1):71-6. PubMed ID: 7672010
[TBL] [Abstract][Full Text] [Related]
20. The interaction of RS 25259-197, a potent and selective antagonist, with 5-HT3 receptors, in vitro.
Wong EH; Clark R; Leung E; Loury D; Bonhaus DW; Jakeman L; Parnes H; Whiting RL; Eglen RM
Br J Pharmacol; 1995 Feb; 114(4):851-9. PubMed ID: 7773546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
